Latest Oncology Stories
Study to focus on mutations and deletions of CREBBP and EP300 genes in lymphomas SAN DIEGO, Jan. 6, 2015 /PRNewswire/ -- Mirati Therapeutics, Inc.
NiCord® is in clinical development as a treatment for blood cancers including leukemia and lymphoma JERUSALEM, January 6, 2015 /PRNewswire/ -- Gamida Cell [http://www.gamida-cell.com
Aldoxorubicin Shows a Complete Response, Tumor Shrinkage, Prolonged Stable Disease, and Favorable Tolerability in Patients LOS ANGELES, Jan.
New IMBRUVICA Data from National Institutes of Health Study Published in The Lancet Oncology SUNNYVALE, Calif., Jan. 5, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
The Mesothelioma Victims Center is sharing a list of current nuclear power plants operating in the United States and urges anyone diagnosed with mesothelioma who worked at one of these facilities to
Two-thirds of all adult cancer cases are primarily the result of “bad luck,” according to the authors of a new study appearing in Friday’s edition of the journal Science.
The Mesothelioma Victims Center will remain open on New Years Day, and throughout the News Year Holiday weekend to ensure a diagnosed victim has instant access to the nation's best mesothelioma
The Mesothelioma Victims Center believes it is nearly impossible for a diagnosed victim of mesothelioma to distinguish between the nation's most skilled mesothelioma compensation lawyers,
- A poem in which the author retracts something said in an earlier poem.